Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xyrem PET Imaging in Narcolepsy
NCT02637076Phase 4Completed
- Sponsor
- Center for Addiction and Mental Health
- Start
- Jan 2016
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sodium oxybate in Narcolepsy type 1 (NT1), sponsored by Center for Addiction and Mental Health. Started Jan 2016; status: completed.
02
Drugs
sodium oxybate
03
Conditions
Narcolepsy type 1 (NT1)
Beyond the preview
Go deeper on NCT02637076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02637076.